Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wallwiener

Showing results (371-380 of 789) with videos related to

Pageof 79
Sort By:
Annals of Surgical Oncology|July 19, 2021
Long-Term Patient Satisfaction and Quality of Life After Breast-Conserving Therapy: A Prospective Study Using the BREAST-QIlona Stolpner, Jörg Heil, Fabian Riedel, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Change in the spectrum of uterus-preserving myoma operations including endoscopy and dual myoma therapy]D Wallwiener, B Aydeniz, S Rimbach, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 13, 2012
Ultrasound guided cryoablation of fibroadenomasM Hahn, D Pavlista, J Danes, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)]K Sotlar, D Diemer, A Stubner, et al.
Molecular and Clinical Oncology|December 2, 2020
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancerRobert Bachmann, Sara Brucker, Annette Stäbler, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2014
Influence of Mifepristone in Induction Time for Terminations in the Second and Third TrimesterM Hoopmann, J Hirneth, J Pauluschke-Fröhlich, et al.
Gynecologic Oncology|January 13, 2019
Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine diseaseP Wagner, F K F Kommoss, S Kommoss, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancerN Fersis, B Smyczek-Gargya, S Armeanu, et al.
Archives of Gynecology and Obstetrics|January 10, 2022
Endometrial hyperplasia as a risk factor of endometrial cancerLisa K Nees, Sabine Heublein, Sahra Steinmacher, et al.
Zentralblatt Fur Gynakologie|January 1, 1995
[Hysteroscopic endometrium ablation in "high-risk" situations and in hemorrhagic diathesis]D Wallwiener, S Rimbach, M Kaufmann, et al.
Pageof 79

Showing results (371-380 of 789) with videos related to

Sort By:
Pageof 79
Annals of Surgical Oncology|July 19, 2021
Long-Term Patient Satisfaction and Quality of Life After Breast-Conserving Therapy: A Prospective Study Using the BREAST-QIlona Stolpner, Jörg Heil, Fabian Riedel, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1996
[Change in the spectrum of uterus-preserving myoma operations including endoscopy and dual myoma therapy]D Wallwiener, B Aydeniz, S Rimbach, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|November 13, 2012
Ultrasound guided cryoablation of fibroadenomasM Hahn, D Pavlista, J Danes, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|November 27, 2007
[Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)]K Sotlar, D Diemer, A Stubner, et al.
Molecular and Clinical Oncology|December 2, 2020
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancerRobert Bachmann, Sara Brucker, Annette Stäbler, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 2014
Influence of Mifepristone in Induction Time for Terminations in the Second and Third TrimesterM Hoopmann, J Hirneth, J Pauluschke-Fröhlich, et al.
Gynecologic Oncology|January 13, 2019
Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine diseaseP Wagner, F K F Kommoss, S Kommoss, et al.
European Journal of Gynaecological Oncology|April 1, 2004
Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancerN Fersis, B Smyczek-Gargya, S Armeanu, et al.
Archives of Gynecology and Obstetrics|January 10, 2022
Endometrial hyperplasia as a risk factor of endometrial cancerLisa K Nees, Sabine Heublein, Sahra Steinmacher, et al.
Zentralblatt Fur Gynakologie|January 1, 1995
[Hysteroscopic endometrium ablation in "high-risk" situations and in hemorrhagic diathesis]D Wallwiener, S Rimbach, M Kaufmann, et al.
Pageof 79